Form 8-K - Current report:
SEC Accession No. 0001521536-11-000142
Filing Date
2011-08-18
Accepted
2011-08-18 13:21:32
Documents
1
Period of Report
2011-08-15
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 q1100126_8k-biozone.htm 8-K 19075
  Complete submission text file 0001521536-11-000142.txt   20355
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 111044420
SIC: 7389 Services-Business Services, NEC